If a drug application is rejected in Taiwan, the TFDA provides feedback detailing the reasons, such as incomplete data or non-compliance with regulations. Applicants can address the issues and resubmit the application. In some cases, additional studies may be required. Engaging with TFDA officials through consultations can help clarify requirements for re-application.
